Reactive oxygen species is essential for cycloheximide to sensitize lexatumumab-induced apoptosis in hepatocellular carcinoma cells.
This study aims to investigate apoptosis induced by lexatumumab (Lexa) in hepatocellular carcinoma (HCC) cells. We assessed the sensitivity of HCC cell lines and normal human hepatocytes to Lexa and explored the sensitization of HCC cells to Lexa-induced apoptosis by cycloheximide (CHX). Our data in...
Main Authors: | Xiangxuan Zhao, Mengde Cao, Joy J Liu, Haizhen Zhu, David R Nelson, Chen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-02-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3037406?pdf=render |
Similar Items
-
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
by: Felley-Bosco Emanuela, et al.
Published: (2007-10-01) -
3D matrix‐embedding inhibits cycloheximide‐mediated sensitization to TNF‐alpha‐induced apoptosis of human endothelial cells
by: Saemisch, Michael, et al.
Published: (2020) -
Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.
by: Xiangxuan Zhao, et al.
Published: (2011-01-01) -
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
by: Birgit Engesæter, et al.
Published: (2012-01-01) -
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
by: Tian Zhigang, et al.
Published: (2008-01-01)